Emerging trends in clinical implications of bio-conjugated silver nanoparticles in drug delivery

• Published in: Colloid and interface science communications Vol. 35; p. 100244
• Main Authors: Prasher, Parteek, Sharma, Mousmee, Mudila, Harish, Gupta, Gaurav, Sharma, Abhishek Kumar, Kumar, Deepak, Bakshi, Hamid A., Negi, Poonam, Kapoor, Deepak N., Chellappan, Dinesh Kumar, Tambuwala, Murtaza M., Dua, Kamal
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.03.2020
• Subjects: AgNPs; Bio-conjugation; Bio-functionalize; Biosensors; Nanopharmaceuticals; MUDA; CTAN; CPP; EDC; Sulfo-NHS; TPE; IgG; PVP; AGB1; CTAB; Sulfo-SMCC; SPDP; MPS; AMPs; APTMS; TBA; Nanopharmaceuticals; MB; NHS; MDR; FRET; Abbreviations; SATA; Bio-conjugation; SWCNT; PDP-PE; MIC; AgNPs; Cdna; PDPSA; RGD; TEOS; Bio-functionalize; PEG; ROS; Biosensors; PDP-PEG-DSPE; TCEP; MPA

From nanopharmaceutics to renewable energy, silver nanoparticles (AgNPs) present innumerable applications in the contemporary era. However, the associated toxicity to the biosystems limits their application. Effective utilization of AgNPs, therefore, requires their surface conjugation with biologica...